Suchergebnisse - "Li, Zhenyu"

PubPharm (28)

1

Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma : a phase I/II trial

enthalten in: Nature communications | 2024

von Shi, M. | Wang, J. | Huang, H. | +19

2

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Ma, S. | Wang, Y. | Qi, K. | +12

3

Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy

enthalten in: Clinical and experimental medicine | 2023

von Cheng, H. | Ji, S. | Wang, J. | +20

4

Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients : A multi-centre study

enthalten in: British journal of haematology | 2023

von Zhou, L. | Fu, W. | Wu, S. | +22

5

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

enthalten in: Cytotherapy | 2023

von Ma, S. | Li, H. | Zhou, D. | +18

6

Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma : A Single-Arm, Phase Ⅱ Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Xia, J. | Li, H. | Yan, Z. | +24

7

Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2023

von Zhou, D. | Wang, Y. | Cheng, H. | +16

8

A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells

enthalten in: Frontiers in immunology | 2023

von Liu, Y. | Jie, X. | Nian, L. | +17

9

Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cells

enthalten in: Frontiers in immunology | 2023

von Lu, Y. | Zhu, H. | Liu, Y. | +12

10

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Wang, Y. | Cao, J. | Gu, W. | +25

CommentIn: Nat Rev Clin Oncol. 2022 Jun;19(6):360. - PMID 35414660